Literature Review

Center for Hospice Care's BreatheEazy Program supports patients with respiratory issues LaporteCounty.Life; by Garrett Spoor; 2/13/25 One of the toughest health challenges a person can face is the trouble of breathing. Center for Hospice Care comes across a lot of patients who experience this issue and encourages many of them to become a part of their BreatheEazy program. Dr. Karissa Misner, medical director at Center for Hospice Care, considers the BreatheEazy program to be a monumental boost for patients who might have respiratory issues. “This is a specialized pulmonary program for our patients with chronic obstructive pulmonary disease,” Misner said. “It can also be used for many other terminal diagnoses that affect the lungs. Whenever there is any type of illness that causes difficulty in breathing, we can utilize this program.”

Valley Hospice House to open Feb. 25, expanding hospice care in the region Bladen Online, Fayetteville, NC; contributed by Cape Fear Valley Health; 2/14/25 Cape Fear Valley Health is proud to announce the official opening of Valley Hospice House, a new, dedicated facility for hospice care, located at 2431 Legion Road. The facility will begin accepting patients on Tuesday, Feb. 25, providing specialized General Inpatient (GIP) Hospice Care and Respite Care in a compassionate, home-like setting. “The opening of Valley Hospice House marks a significant step forward in enhancing hospice services for our community,” said Susan Dees, Chief Nursing Executive. 

What's keeping CFOs up at night? Becker's Hospital CFO Report; by Alan Condon; 2/14/25 As health system CFOs chart their course for 2025, they face an increasingly complex financial landscape marked by mounting labor costs, tightening margins, shifting payer dynamics and an evolving regulatory environment. ... [Several] CFOs recently joined the “Becker's CFO and Revenue Cycle Podcast” to discuss the trends they're watching most closely — and the strategies they're deploying to stay ahead. [Key items include the following: labor shortages (key theme); major investments in ambulatory care facilities; AI to support operations and service; physician partnerships; shift from fee for service to value-based care; clinical labor; malpractice litigation; growth of Medicare Advantage programs; staffing shortages; inflation; reimbursements; providing care to undersinsured patients; Medicaid supplemental funding programs; "disruptors' by private equity and "other nontraditional players"; uncertainty of federal and state regulation changes.]

Patrick Mahomes' grandfather dies days after Chiefs' Super Bowl heartbreak Fox News; by Paulina Dedaj; 2/14/25 The grandfather of Kansas City Chiefs quarterback Patrick Mahomes has died just weeks after being put in hospice care, the NFL star’s mother confirmed Friday. Randi Mahomes shared a post on Instagram announcing the passing of her father, Randy. The heartbreaking news for the Mahomes family comes just days after the Chiefs suffered a crushing loss to the Philadelphia Eagles in Super Bowl LIX. [Click here for their previous post, Patrick Mahomes' grandfather reportedly 'hanging on' in hospice care to watch grandson play in Super Bowl LIX]

Leadership should be born out of understanding the needs of those who will be affected by it. ~ Marian Anderson

57 health systems on Forbes' list of best large employers Becker's Hospital Review; by Kelly Gooch; 2/13/25 Forbes released its annual ranking of America's best large employers Feb. 12, and it included 57 hospitals and health systems. The publication partnered with market research firm Statista to compile lists of the top large and midsize employers in the U.S. after surveying more than 217,000 employees working at companies within the U.S. that employ more than 1,000 people. Companies with more than 5,000 employees were considered for the large employers ranking. Survey participants were asked whether they would recommend their employer to others and to rate it based on criteria such as pay, work environment, training programs and advancement opportunities. [The top 5 include the following. Click on the title's link for the full list and links to more info.]

Local hospice clinic reacts to doctor’s death NBC 11, CBS 13, Fox 9, Yuma, AZ; by Miriam Ordonez and Dillon Fuhrman; 2/12/25 A Yuma physician has been identified as the victim of a fatal vehicle crash that took place early Monday morning. 75-year-old William Michael Shea, a longtime doctor at Hospice of Yuma, was struck while crossing S. James Drive at East 24th Street. Authorities say the driver, a 65-year-old woman, was turning onto James Road from 24th Street when the accident happened. Shea was rushed to Onvida Health, where he later died from his injuries. Hospice of Yuma shared their sadness over Dr. Shea's passing, calling him a beloved leader whose "dedication, compassion and leadership touched countless lives."

How medtech is meeting the demand for hospital-at-home care Modern Healthcare; by Lauren Dubinsky; 2/13/25 Medtech companies have their eye on the growing hospital-at-home market, which is driven largely by the rising elderly population, the prevalence of chronic diseases and favorable reimbursement policies. There have been hiccups but some of the largest health systems have leaned into providing hospital-level care at home. ... The desire to safely provide care for patients at home is creating a ripe opportunity for companies like Masimo, Cardinal Health, Medline Industries and McKesson, despite some uncertainty. The global home healthcare market was valued at $257 billion in 2023 and is projected to reach nearly $531 billion by 2032, according to a Vantage Market Research report published in September.

Humana posts $693M loss in Q4 Becker's Payer Issues; by Jakob Emerson; 2/11/25 Humana lost $693 million in the fourth quarter of 2024, according to the company's year-end earnings report published Feb. 11. The results reflect increased benefits expenses, particularly in Medicare Advantage and state-based contracts. Despite the challenges, the company projected earnings per share of $15.88 for 2025, with an adjusted EPS of approximately $16.25. Total revenues in the fourth quarter were $29.2 billion, up 10.4% year over year. In 2024, total revenues were $117.8 billion, up 10.7%. Humana posted a net loss of $693 million in the fourth quarter, compared to a $541 million net loss the year prior. In 2024, the company's net income totaled nearly $1.2 billion, down 52%.

Advanced cardiac care boosts symptom management, quality of life Carolina Caring, Newton, NC; by Cassidy Collins; 2/12/25 For those living with advanced heart disease or heart failure diagnoses, access to the right medical care can greatly improve their quality of life. This Heart Month, Carolina Caring is spotlighting the Advanced Cardiac Care Program, which provides treatment and clinical support to help patients with heart failure manage their symptoms from wherever they call home. It is the first program of its kind in North Carolina and one of the first established in the nation. It also recognized as a Certified Care program in Palliative/Hospice Heart Failure from the American Heart Association (AHA). Since this certification, Carolina Caring saw a drop to zero readmissions for primary congestive heart failure Hospice patients by the end of 2024. The benefits of this comprehensive, home-based cardiac care program are best illustrated through individuals such as Shirley, a hospice patient who began her journey with Carolina Caring last spring.

Hospice leaders applaud CMS’s decision to reevaluate Special Focus Program, call for meaningful reforms National Alliance for Care at Home, Washington, DC and Alexandria, VA; Press Release; 2/14/25 Effective February 14, 2025, the Centers for Medicare & Medicaid Services (CMS) has ceased the implementation of the Hospice Special Focus Program (SFP) so that CMS may further evaluate the program. This decision is a positive move acknowledging that the current approach is not working as intended. The hospice community has long advocated for strong oversight and patient protections, but the SFP, as implemented, was deeply flawed, unlawful, and harmful to the very patients it was meant to protect. A multi-state coalition of hospices and hospice associations took legal action in January to challenge the program, citing its misrepresentation of hospice compliance records, misleading data, and jeopardized access to high-quality end-of-life care. The flawed algorithm behind the SFP failed to distinguish fraudulent providers from reputable ones, disproportionately penalized well-established hospices, and ignored repeated warnings from congressional leaders and industry stakeholders. ... Now that CMS is reassessing its approach, there is an opportunity to ensure that oversight efforts truly enhance patient protections without restricting access to trusted hospice providers. The National Alliance for Care at Home (the Alliance) and the National Partnership for Healthcare and Hospice Innovation (NPHI) remain committed to protecting access to high-quality hospice care and ensuring that regulatory oversight is fair, transparent, and aligned with congressional intent. ... [Click on the title's link to continue reading.] 

Suzetrigine: First-in-class nonopioid pain therapy is approved by FDAAmerican Journal of Managed Care; Giuliana Grossi; 1/25Suzetrigine (Journavx; Vertex Pharmaceuticals) received approval from the FDA for the treatment of adults with moderate-to-severe acute pain, according to an announcement from Vertex. The therapy is a novel oral, non-opioid, highly selective NaV1.8 pain signal inhibitor ... offering a non-opioid alternative amid the opioid crisis. Clinical trials demonstrated significant efficacy in postsurgical pain relief, though results varied across different conditions. Despite this, suzetrigine offers the potential to energize the nonopioid pain market, which includes other companies like Tris Pharma, Latigo Biotherapeutics, and SiteOne Therapeutics—all actively developing alternatives to opioids. Key findings from the Institute for Clinical and Economic Review analysis of the phase 3 trials include potential lifetime cost savings of $200 per patient when comparing suzetrigine with opioids, assuming a 1-week course priced at $420.

Researchers outline new research priorities in neuropalliative care UNC Health and UNC School of Medicine, Chapel Hill, NC; by Winnie K. Lau, MD and David Y. Hwang, MD2/7/25... An emerging field, termed “neuropalliative care,” has taken shape over the past few years to help provide impactful, holistic care for patients with serious neurological disease. And now, experts in the field are seeking ways to improve the overall wellbeing of their patients and loved ones through the power of research. ... A special communication in JAMA Neurology, first-authored by Winnie K. Lau, MD, a neurocritical care physician and associate professor of neurology and senior-authored by David Y. Hwang, MD, professor of neurology and division chief of neurocritical care, describes needed research that can help advance patient care, including: